Compare Goodyear Tire & Rubber Co (GT) vs Medtronic PLC (MDT) Price & Performance

Goodyear Tire & Rubber (GT) trades at $4.69, up 0.64% on the day, but remains near 52-week lows amid a bearish technical outlook. The company reported a Q2 2026 loss of $0.61 per share, beating estimates but reflecting ongoing volume pressures. Revenue has declined from $20.8B in 2022 to $18.3B in 2025, with a net income margin of -14.37% in the latest period. Despite a low P/E of 4.69 and P/B of 0.48, negative ROE and ROA highlight profitability challenges. Recent news highlights a restructuring plan targeting margin improvement and debt reduction.

The outlook is mixed, with a consensus price target of $8.00 suggesting significant upside if restructuring succeeds. However, risks include persistent volume declines, high debt levels, and execution uncertainty. Analyst sentiment is cautious with 34.62% buy ratings, 50% hold, and 15.38% sell. Investors should weigh the deep value metrics against fundamental headwinds in the competitive tire industry.

Medtronic (MDT) trades at $85.51, down 1.81% on the day, with the stock showing bearish technical signals despite strong fundamental performance. The company has beaten earnings expectations for three consecutive quarters, maintains a healthy 13.93% net income margin, and offers a solid 3.2% dividend yield with 49 consecutive years of dividend growth. Recent positive developments include FDA clearances for new medical technologies and raised full-year guidance.

MDT presents a compelling value opportunity with analyst consensus pointing to 14% upside to the $97.80 price target. The stock's current valuation multiples (P/E 21.61, P/S 3.01) appear reasonable given the company's stable revenue growth and strong cash flow generation. Key risks include increasing debt levels and competitive pressures in the medical device sector, but the company's dividend aristocrat status and improving operational performance support a positive long-term outlook.